Seth Harmon's most recent trade in Viridian Therapeutics Inc was a trade of 150,407 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viridian Therapeutics Inc | Seth Harmon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 150,407 | 150,407 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Seth Harmon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,068 | 25,068 | - | - | Restricted Stock Units |